A large South Korean cohort study from 2024 examined whether peptic ulcer disease (PUD) and Helicobacter pylori eradication therapy influence dementia risk in adults aged 55–79.
Using national health insurance data from 2002–2015 and propensity score matching, researchers assessed overall dementia and Alzheimer’s disease (AD) over 5–10 years. While the researchers did not directly verify the presence of the bacteria, their findings were based on treatment history.
The results showed that PUD was associated with a higher risk of developing dementia, with a stronger link for overall dementia than for AD. Eradication therapy itself did not markedly change overall risk, but later treatment was associated with greater dementia risk, highlighting the importance of timely management. Age-stratified analyses also indicated elevated AD risk, particularly in individuals in their 60s and 70s.
Overall, the findings suggest that PUD is a risk factor for dementia in older adults, and that early treatment of H. pylori infection may play a role in prevention strategies for neurodegenerative diseases.
Learn more about this study here: https://doi.org/10.1007/s11357-024-01284-z
Reference
Kang, D.W., Lee, JW., Park, M.Y. et al. Impact of Helicobacter pylori eradication on age-specific risk of incident dementia in patients with peptic ulcer disease: a nationwide population-based cohort study. GeroScience 47, 1161–1174 (2025).

